from Reuters: Health https://ift.tt/2YfOWEL
Wednesday, 29 April 2020
BerGenBio shares soar on COVID-19 drug trial news
Shares of Norway's BerGenBio more than doubled on Wednesday after a cancer drug it is developing was selected for a British trial of potential COVID-19 treatments, the latest instance of a firm seeking to re-purpose a medicine to fight the pandemic.
from Reuters: Health https://ift.tt/2YfOWEL
from Reuters: Health https://ift.tt/2YfOWEL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment